---
title: Ultrasound-guided Genicular Nerves Block
nct_id: NCT05813834
overall_status: COMPLETED
phase: NA
sponsor: Cairo University
study_type: INTERVENTIONAL
primary_condition: Genicular Nerve Block for Pain in ACL Arthroscopy
countries: Egypt
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT05813834.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT05813834"
ct_last_update_post_date: 2024-11-14
last_seen_at: "2026-05-12T06:35:24.285Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Ultrasound-guided Genicular Nerves Block

**Official Title:** US-guided Genicular Nerves Block for Pain Control After Arthroscopic Anterior Cruciate Ligament Repair: A Prospective, Double Blinded, Randomized Controlled Study

**NCT ID:** [NCT05813834](https://clinicaltrials.gov/study/NCT05813834)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 56
- **Lead Sponsor:** Cairo University
- **Conditions:** Genicular Nerve Block for Pain in ACL Arthroscopy
- **Start Date:** 2023-06-01
- **Completion Date:** 2024-03-30
- **CT.gov Last Update:** 2024-11-14

## Brief Summary

Most of arthroscopic ACL repairs are day case surgeries associated with moderate postoperative pain and discomfort. So , finding an effective and safe, analgesic technique with minimal complications is our goal for fast recovery and short hospital stay.

in this study, we aim to compare the efficacy of genicular nerve block against controls on postoperative pain scores, the need for rescue analgesics, patient's satisfaction and range of motion (ROM) after arthroscopic ACL cases.

## Detailed Description

In this study, we aim to compare the efficacy of genicular nerve block against controls on postoperative pain scores, the need for rescue analgesics, patient's satisfaction and range of motion (ROM) after arthroscopic ACL cases.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 65 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* both genders
* age 18 - 65
* ASA i, ii, iii

Exclusion Criteria:

* ROM less than 90
* advanced renal or liver diseases
* patient refusal
* substance abuse
* site infection
* known sensitivity to any of study drugs
```

## Arms

- **genicular nerve block group** (ACTIVE_COMPARATOR) — patients will receive genicular nerves block
- **control group** (NO_INTERVENTION) — patients will not receive genicular nerves block

## Interventions

- **Genicular Nerves Block** (PROCEDURE) — US guided genicular nerves block

## Primary Outcomes

- **post operative VAS** _(time frame: 24 hours)_ — vas score

## Secondary Outcomes

- **total morphine consumption** _(time frame: 24 hours)_
- **time to first morphine analgesia** _(time frame: 24 hours)_
- **range of motion** _(time frame: 24 hours)_
- **post operative MAP** _(time frame: 24 hours)_

## Locations (1)

- faculty of medicine Cairo university, Cairo, Egypt

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.faculty of medicine cairo university|cairo||egypt` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT05813834.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT05813834*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*